Machine-Learning-Assisted Risk Stratification for Tuberculosis Infection in High-Risk Groups Receiving Immunosuppressive Therapy
Machine-Learning-gestützte Risikostratifizierung für Tuberkuloseinfektion in Hochrisikogruppen unter immunsuppressiver Therapie
Diagnostics · 09.11.2026 · 16 (21) · 3693
DOI: 10.3390/diagnostics16213693 ↗Auf einen Blick
Bei 544 Erwachsenen war der Anteil positiver immunologischer Tests je nach Risikogruppe deutlich unterschiedlich. Besonders hoch war er bei Herztransplantat-Empfänger:innen und Haushaltskontakten.
Fragestellung
Wie häufig zeigen verschiedene Hochrisikogruppen unter immunsuppressiver Therapie immunologische Hinweise auf eine Tuberkuloseinfektion, und lassen sich individuelle Risiken per Machine Learning stratifizieren?
Methode
Beobachtungsstudie mit 544 Erwachsenen von 2023 bis 2026; klinische, epidemiologische, radiologische und immunologische Untersuchung. Explorative logistische Regression und Decision-Tree-Modelle; 5 × 10-fache Cross-Validation mit Bootstrap-Korrektur.
Ergebnisse
Positive Tests: Herztransplantat-Empfänger:innen 15/28 (53,6 %), Haushaltskontakte 12/29 (41,4 %), prätransplantär 5/14 (35,7 %), Tuberkulose-Facility-Healthcare-Worker 21/93 (22,6 %), gesunde Kontrollen 3/69 (4,4 %). AUC 0,670 bzw. 0,668 in zwei Subgruppen.
Einschränkungen
Modelle nur explorativ, kleine und klinisch heterogene Subgruppen, keine externe Validierung.
Schlussfolgerung der Autor:innen
Die Prävalenz immunologischer Hinweise auf Tuberkuloseinfektion variierte stark zwischen den Risikogruppen. Epidemiologische Exposition und Art der immunsuppressiven Therapie sollten gemeinsam betrachtet werden.
Kernaussagen
- Hohe Positivitätsraten bei Herztransplantat-Empfänger:innen und Haushaltskontakten
- AUC 0,670 und 0,668 in zwei explorativen Subgruppenmodellen
- Explorative Modelle ohne externe Validierung und mit kleinen Subgruppen
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 09.11.2026. Verfasst von Anna Starshinova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Almazov National Research Medical Center, 197341 St. Petersburg, Russia. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Saint Petersburg International Mathematical Institute, Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
Background
Individuals receiving immunosuppressive therapy, solid-organ transplant recipients, household contacts of patients with tuberculosis, and healthcare workers are at increased risk of Mycobacterium tuberculosis infection and progression to tuberculosis disease. However, currently available immunological tests cannot reliably distinguish tuberculosis infection from active tuberculosis disease or predict individual progression to disease. We aimed to assess the prevalence of immunological evidence of tuberculosis infection across clinically and epidemiologically distinct risk groups and to explore the potential of machine-learning methods for individualised risk stratification.
Methods
In this observational study, 544 adults aged 18–75 years were assessed between 2023 and 2026. Participants included patients with pulmonary tuberculosis, tuberculosis-facility healthcare workers, healthcare workers in the general medical network, household and occupational contacts of patients with tuberculosis, patients with rheumatic diseases receiving immunosuppressive therapy, patients undergoing assessment for heart transplantation, heart-transplant recipients, and healthy controls. Participants underwent clinical, epidemiological, radiological, and immunological assessment, including interferon-γ release assays (ELISPOT and QuantiFERON-TB Gold) and the tuberculosis recombinant allergen skin test. Individuals with positive immunological tests underwent additional assessment to exclude active tuberculosis. Exploratory logistic regression and decision-tree models were developed separately for each risk group using demographic and treatment-related variables. Model performance was estimated using repeated stratified 5-fold cross-validation (5 × 10 repeats) with bootstrap optimism correction; discrimination, calibration, sensitivity, specificity, positive and negative predictive values, Cohen’s kappa, and Matthews correlation coefficient were reported with 95% confidence intervals.
Results
The prevalence of positive immunological tests was highest among heart-transplant recipients (15 [53.6%] of 28), followed by household contacts (12 [41.4%] of 29), patients undergoing pre-transplant assessment (5 [35.7%] of 14), and tuberculosis-facility healthcare workers (21 [22.6%] of 93). Positivity was lower among patients with rheumatic diseases receiving immunosuppressive therapy (11 [13.9%] of 79) and healthcare workers in the general medical network without documented tuberculosis exposure (7 [10.5%] of 68), and was 3 (4.4%) of 69 among healthy controls. Compared with healthy controls, positivity was significantly higher among tuberculosis-facility healthcare workers, household contacts, patients with rheumatic diseases, and pre-transplant and heart-transplant populations. Exploratory machine-learning analyses were performed separately for the two clinically most relevant immunosuppressed subgroups. In patients with rheumatic diseases (n = 71; 9 positive, 62 negative), pooled ROC AUC was 0.670 (95% CI 0.520–0.824, participant-level bootstrap); age showed 100% bootstrap sign consistency, whereas bDMARD treatment showed 84.6% and sex 55.0%. In the combined heart transplantation group (n = 41; 19 positive, 22 negative), pooled ROC AUC was 0.668 (95% CI 0.522–0.811); tacrolimus and everolimus showed the highest bootstrap sign consistency (100% and 97.6%, respectively); however, because tacrolimus and everolimus are administered predominantly to transplant recipients, these coefficients may partly reflect transplantation status rather than drug-specific effects. Because the heart transplantation group combines pre-transplant candidates and recipients, and because both subgroups had small numbers of events, these associations should be interpreted as exploratory and not as drug-specific causal effects.
Conclusions
The prevalence of immunological evidence of tuberculosis infection varied substantially between risk groups and was particularly high among household contacts and heart-transplant recipients. The findings suggest that epidemiological exposure and the type of immunosuppressive therapy should be considered jointly when assessing tuberculosis infection risk. Exploratory machine-learning analyses suggested that treatment-related variables may contribute to individualised risk stratification in the combined heart transplantation group, but the models were developed in small, clinically heterogeneous subgroups and were not externally validated. They should therefore be regarded as hypothesis-generating. Prospective multicentre studies with longitudinal follow-up are required to determine whether integrated clinical, epidemiological, immunological, and treatment-related models can predict incident tuberculosis disease and improve targeted preventive strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Almazov National Research Medical Center, 197341 St. Petersburg, Russia.
- Faculty of Mathematics and Computer Science, St. Petersburg State University, 199034 St. Petersburg, Russia.
- Medical Department, Bashkir State Medical University of the Ministry of Health of the Russian Federation, 450000 Ufa, Russia.
- Medical Department, St. Petersburg State Medical University Named After Academician I.P. Pavlov, 197376 St. Petersburg, Russia.
- St. Petersburg Research Institute of Phthisiopulmonology, 191036 St. Petersburg, Russia.
- St. Petersburg State Budgetary Healthcare Institution "City Tuberculosis Dispensary", 127006 St. Petersburg, Russia.
ORCID-Profile: Anna Starshinova, Raul Sharipov, Nikolay N Osipov, Dmitry Kudlay
Förderung
- Saint Petersburg International Mathematical Institute
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Starshinova, A., Sabirova, A., Koroteeva, O., Sharipov, R., Panteleev, A., Nazarenko, M., Osipov, N. N., Spelnikov, D., & Kudlay, D. (2026). Machine-Learning-Assisted Risk Stratification for Tuberculosis Infection in High-Risk Groups Receiving Immunosuppressive Therapy. Diagnostics, 16(21), 3693. https://doi.org/10.3390/diagnostics16213693
Vancouver
Starshinova A, Sabirova A, Koroteeva O, Sharipov R, Panteleev A, Nazarenko M, et al. Machine-Learning-Assisted Risk Stratification for Tuberculosis Infection in High-Risk Groups Receiving Immunosuppressive Therapy. Diagnostics. 2026;16(21):3693. doi:10.3390/diagnostics16213693
BibTeX
@article{Starshinova2026,
author = {Starshinova, Anna and Sabirova, Adilia and Koroteeva, Olesia and Sharipov, Raul and Panteleev, Aleksandr and Nazarenko, Michail and Osipov, Nikolay N and Spelnikov, Dmitry and Kudlay, Dmitry},
title = {Machine-Learning-Assisted Risk Stratification for Tuberculosis Infection in High-Risk Groups Receiving Immunosuppressive Therapy},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {21},
pages = {3693},
doi = {10.3390/diagnostics16213693}
}
EUVIMED